Update on COVID-19 Infection and Ivermectin Treatment

References (42)

1. 1 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [DOI]
2. 2 A pneumonia outbreak associated with a new coronavirus of probable bat origin [DOI]
3. 3 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [DOI]
4. 4 La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
5. 5 A new coronavirus associated with human respiratory disease in China [DOI]
6. 6 Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding [DOI]
7. 7 Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro [DOI]
8. 8 First Case of 2019 Novel Coronavirus in the United States [DOI]
9. 9 The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China [DOI]
10. 10 Coronaviruses: An Overview of Their Replication and Pathogenesis [DOI]
11. 11 Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan [DOI]
12. 12 The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro [DOI]
13. 13 Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC [DOI]
14. 14 Coronaviruses post-SARS: update on replication and pathogenesis [DOI]
15. 15 Viral load of SARS-CoV-2 in clinical samples [DOI]
16. 16 Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China [DOI]
17. 17 Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020 [DOI]
18. 18 Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response [DOI]
19. 19 Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‐CoV‐2 infection [DOI]
20. 20 2019-nCoV transmission through the ocular surface must not be ignored [DOI]
21. 21 Coronavirus Genomics and Bioinformatics Analysis [DOI]
22. 22 Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans [DOI]
23. 23 Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible? [DOI]
24. 24 Bat Coronaviruses in China [DOI]
25. 25 Coronavirus Disease - COVID-19 [DOI]
26. 26 Ocular Tropism of Respiratory Viruses [DOI]
27. 27 Cleavage and Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by Human Airway Trypsin-Like Protease [DOI]
28. 28 Genetic Characterization of Betacoronavirus Lineage C Viruses in Bats Reveals Marked Sequence Divergence in the Spike Protein of Pipistrellus Bat Coronavirus HKU5 in Japanese Pipistrelle: Implications for the Origin of the Novel Middle East Respiratory Syndrome Coronavirus [DOI]
29. 29 Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63 [DOI]
30. 30 Feigin & Cherry's textbook of pediatric infectious diseases
31. 31 Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques [DOI]
32. 32 SARS-related Virus Predating SARS Outbreak, Hong Kong [DOI]
33. 33 Transmission Routes Analysis of SARS-CoV-2: A Systematic Review and Case Report [DOI]
34. 34 ANCA-Associated Vasculitis — Refining Therapy with Plasma Exchange and Glucocorticoids [DOI]
35. 35 Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63 [DOI]
36. 36 Diagnosis of Severe Acute Respiratory Syndrome (SARS) by Detection of SARS Coronavirus Nucleocapsid Antibodies in an Antigen-Capturing Enzyme-Linked Immunosorbent Assay [DOI]
37. 37 Feigin and Cherry's Textbook of Pediatric Infectious Diseases [DOI]
38. 38 Molecular Evolution Analysis and Geographic Investigation of Severe Acute Respiratory Syndrome Coronavirus-Like Virus in Palm Civets at an Animal Market and on Farms [DOI]
39. 39 SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission [DOI]
40. 40 Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody [DOI]
41. 41 Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva [DOI]
42. 42 The infection evidence of SARS-COV-2 in ocular surface: a single-center cross-sectional study [DOI]

Cited by 1

Related research

• Trichomonas vaginalis Infection in a Typical Urban and a Suburban Area of Rivers State Nigeria — shares topic coverage
• Seroprevalence and Risk of Toxoplasma gondii Infection among Pregnant Women at Federal Teaching Hospital Gombe, Nigeria — shares topic coverage
• Alternative Strategies in the Treatment of Clostridioides difficile Infection — shares topic coverage
• Secondary Infertility in Port Harcourt: Pattern and Socio-Dermographic Relationship — shares topic coverage
• Anaemia a Monitoring Tool for Helminth Infection — shares topic coverage